Cardiovascular Health | Sugar-Controlling Probiotics Flash-Release Tablet

Sugar-controlling probiotics are a category of probiotics that assist in blood glucose management by modulating the human microbial community, exemplified by strains like Limosilactobacillus reuteri GL-104 and Ligilactobacillus salivarius AP-32. They primarily function by regulating the balance of gut microbiota, inhibiting the growth of harmful bacteria, promoting the proliferation of beneficial bacteria, and improving the intestinal microecology. Furthermore, they enhance intestinal barrier function, reducing chronic inflammation triggered by endotoxin translocation into the bloodstream - a significant contributor to insulin resistance. These probiotics also influence metabolic pathways, such as promoting the secretion of glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity. Specifically, Ligilactobacillus salivarius AP-32 may additionally reduce oral pathogenic bacteria associated with dysglycemia. Supplementing with these specific strains helps stabilize postprandial blood glucose levels, lower glycated hemoglobin (HbA1c) levels, and improve insulin resistance.